Table 1.
Mutant | IC50 (nM) | |||
---|---|---|---|---|
WT | KKVEW | 0.46 | 1 | |
41AAA43 | KKAAA | 7,820 | 17,000 | |
V41A | KKAEW | 23 | 50 | |
V41D | KKDEW | 400 | 870 | |
W43A | KKVEA | 230 | 500 | |
W43F | KKVEF | 1.5 | 3 | |
W43Y | KKVEY | 1.5 | 3 | |
E42A | KKVAW | 1 | 2 | |
E42C | KKVCW | 2.3 | 5 | |
E42T | KKVTW | 0.5 | 1 | |
42EW43/RF | KKVRF | 0.7 | 2 | |
42EW43/HY | KKVHY | 1.4 | 3 | |
39KK40/NN | NNVEW | 22 | 47 |
The IC50’s were determined by inhibition of PP1 activity as described in Fig. 1. Mutated residues are shown in bold.